INTREPID

INTREPID project aims at developing a multi-sensor wearable system for the treatment of phobias and situational anxiety. INTREPID project actively contributes to the treatment of phobias in an unobtrusive, personalized and intelligent manner.

INTREPID will serve to empower Community citizens in the management of their individual health, to provide health care professionals and facilities with a reliable phobias treatment and decision support tool and to create new opportunities for the medical wearable device industry. INTREPID will build upon the well documented increasing demand for "healthy lifestyle" products and services on the consumer side and offer potentially significant returns for those who chose to invest in the project outcome.

The INTREPID project scientific objectives are:

  • To effectively exploit the synergy in the information acquired from the various biometric sensors and develop new and efficient data fusion techniques, which will significantly broaden machine perception and enhance awareness of the phobia's states.
  • To create an identification system of the physiological and phobia-based emotional state of a patient (phobia's state) that will be based on the association of the information coming from the various biometric sensors.
  • To create a decision-making system that will project the current patient's phobia state into the future and draw inferences about the actions that should be taken in order to keep the patient in the desired phobia's state.
  • To create a new centralised sensor management system that will use active and selective perception techniques in order to optimize the overall performance of the identification system and the tracking system.
  • To create a powerful, intelligent and innovative humancomputer interaction environment that will boost the research and work on affective wearable computing and machine emotional intelligence domain.

The INTREPID project technological objectives are:

  • To create an advanced tracking system that will optimally monitor the symptoms of phobias. The system will measure heart rate, perspiration rate, breath rate, muscle stiffness and if needed complementary modalities through a set of miniaturized wearable sensors that the patient wears during the treatment session.
  • To create a sophisticated environment in a commercial wearable computer that will consist of:
  • To create a professional site for psychologists and therapists that will assist them to design the next steps of the patient's therapy taking into account the individualized physiological and emotional state of each patient.

For further information, please visit:
http://www.intrepid-project.org

Project co-ordinator:
Manchester University (UK)

Partners:

  • UNIMAN (UK)
  • ESIEA (FR)
  • AURELIA MICRO (IT)
  • UoI (EL)
  • PALADION (EL)
  • Elyros (BE)
  • InFocus (UK)

Timetable: from 01/04 to 12/06

Total cost: € 3,228,334

EC funding: € 2,000,000

Instrument: STREP

Project Identifier: IST-2002-507464

Source: FP6 eHealth Portfolio of Projects

Most Popular Now

New AI Tool Predicts Protein-Protein Int…

Scientists from Cleveland Clinic and Cornell University have designed a publicly-available software and web database to break down barriers to identifying key protein-protein interactions to treat with medication. The computational tool...

AI for Real-Rime, Patient-Focused Insigh…

A picture may be worth a thousand words, but still... they both have a lot of work to do to catch up to BiomedGPT. Covered recently in the prestigious journal Nature...

New Research Shows Promise and Limitatio…

Published in JAMA Network Open, a collaborative team of researchers from the University of Minnesota Medical School, Stanford University, Beth Israel Deaconess Medical Center and the University of Virginia studied...

G-Cloud 14 Makes it Easier for NHS to Bu…

NHS organisations will be able to save valuable time and resource in the procurement of technologies that can make a significant difference to patient experience, in the latest iteration of...

Start-Ups will Once Again Have a Starrin…

11 - 14 November 2024, Düsseldorf, Germany. The finalists in the 16th Healthcare Innovation World Cup and the 13th MEDICA START-UP COMPETITION have advanced from around 550 candidates based in 62...

Hampshire Emergency Departments Digitise…

Emergency departments in three hospitals across Hampshire Hospitals NHS Foundation Trust have deployed Alcidion's Miya Emergency, digitising paper processes, saving clinical teams time, automating tasks, and providing trust-wide visibility of...

MEDICA HEALTH IT FORUM: Success in Maste…

11 - 14 November 2024, Düsseldorf, Germany. How can innovations help to master the great challenges and demands with which healthcare is confronted across international borders? This central question will be...

A "Chemical ChatGPT" for New M…

Researchers from the University of Bonn have trained an AI process to predict potential active ingredients with special properties. Therefore, they derived a chemical language model - a kind of...

Siemens Healthineers co-leads EU Project…

Siemens Healthineers is joining forces with more than 20 industry and public partners, including seven leading stroke hospitals, to improve stroke management for patients all over Europe. With a total...

MEDICA and COMPAMED 2024: Shining a Ligh…

11 - 14 November 2024, Düsseldorf, Germany. Christian Grosser, Director Health & Medical Technologies, is looking forward to events getting under way: "From next Monday to Thursday, we will once again...

In 10 Seconds, an AI Model Detects Cance…

Researchers have developed an AI powered model that - in 10 seconds - can determine during surgery if any part of a cancerous brain tumor that could be removed remains...

Does AI Improve Doctors' Diagnoses?

With hospitals already deploying artificial intelligence to improve patient care, a new study has found that using Chat GPT Plus does not significantly improve the accuracy of doctors' diagnoses when...